BioCurex, Inc.(fka BOCX)

[Norad]

"They obviously don't believe that BOCX has the goods to make recaf viable."

You bring to mind something I was wandering about the other day.

From the Tumor Biology abstract
"Conclusions: We developed a non-radioactive RECAF CIA assay that separates multiple types of cancer from normal
sera with a C/N ratio ranging from 1.3 to 1.7. Our future studies will focus on increasing the cancer/normal ratio to create a manufacturable RECAF CIA assay."

The word that really sticks out here is manufacturable. How high do they have to get the C/N ratio? Assuming the C/N range is the predominent variable for manufacturability, how is it that the current PSA test was ever manufacturable? What was the C/N ratio for the PSA test when it was in the stage of development that RECAF Serum CIA is in now?

Any thoughts would be appreciated.